Literature DB >> 8604170

Trends in infectious diseases mortality in the United States.

R W Pinner1, S M Teutsch, L Simonsen, L A Klug, J M Graber, M J Clarke, R L Berkelman.   

Abstract

OBJECTIVE: To evaluate recent trends in infectious diseases mortality in the United States.
DESIGN: Descriptive study of infectious disease mortality, classifying International Classification of Diseases, Ninth Revision codes as infectious diseases, consequence of infectious diseases, or not infectious diseases. Multiple cause-of-death tapes from the National Center for Health Statistics for the years 1980 through 1992 were used, with a focus on underlying cause-of-death data and on codes that exclusively represent infectious diseases.
SETTING: United States.
SUBJECTS: All persons who died between 1980 and 1992. MAIN OUTCOME MEASURE: Death.
RESULTS: Between 1980 and 1992, the death rate due to infectious diseases as the underlying cause of death increased 58%, from 41 to 65 deaths per 100,000 population in the United States. Age-adjusted mortality from infectious diseases increased 39% during the same period. Infectious diseases mortality increased 25% among those aged 65 years and older (from 271 to 338 per 100,000), and 6.3 times among 25- to 44-year-olds (from six to 38 deaths per 100,000). Mortality due to respiratory tract infections increased 20%, from 25 to 30 deaths per 100,000, deaths attributed to human immunodeficiency virus increased from virtually none to 13 per 100,000 in 1992, and the rate of death due to septicemia increased 83% from 4.2 to 7.7 per 100,000.
CONCLUSIONS: Despite historical predictions that infectious diseases would wane in the United States, these data show that infectious diseases mortality in the United States has been increasing in recent years.

Entities:  

Mesh:

Year:  1996        PMID: 8604170

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  89 in total

1.  Long-term trends in childhood infectious disease mortality rates.

Authors:  J H DiLiberti; C R Jackson
Journal:  Am J Public Health       Date:  1999-12       Impact factor: 9.308

2.  Activation of extracellular signal-related protein kinases 1 and 2 of the mitogen-activated protein kinase family by lipopolysaccharide requires plasma in neutrophils from adults and newborns.

Authors:  S Bonner; S R Yan; D M Byers; R Bortolussi
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

3.  Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America.

Authors:  J G Bartlett; S F Dowell; L A Mandell; T M File; D M Musher; M J Fine
Journal:  Clin Infect Dis       Date:  2000-09-07       Impact factor: 9.079

4.  rpoB gene analysis as a novel strategy for identification of spirochetes from the genera Borrelia, Treponema, and Leptospira.

Authors:  P Renesto; K Lorvellec-Guillon; M Drancourt; D Raoult
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

5.  Motualevic acids and analogs: synthesis and antimicrobial structure-activity relationships.

Authors:  Pradeep Cheruku; Jessica L Keffer; Cajetan Dogo-Isonagie; Carole A Bewley
Journal:  Bioorg Med Chem Lett       Date:  2010-06-09       Impact factor: 2.823

6.  Colony-Stimulating Factors in the Therapeutic Approach to Sepsis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

7.  Emerging opportunistic fungal infections: where are we heading?

Authors:  Vincent Idemyor
Journal:  J Natl Med Assoc       Date:  2003-12       Impact factor: 1.798

Review 8.  Laboratory diagnosis of lower respiratory tract infections: controversy and conundrums.

Authors:  Karen C Carroll
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

9.  Racial and ethnic differences in the seroprevalence of 6 infectious diseases in the United States: data from NHANES III, 1988-1994.

Authors:  Geraldine M McQuillan; Deanna Kruszon-Moran; Benny J Kottiri; Lester R Curtin; Jacqueline W Lucas; Raynard S Kington
Journal:  Am J Public Health       Date:  2004-11       Impact factor: 9.308

Review 10.  [New medications for treatment of systemic mycoses].

Authors:  I Schedel
Journal:  Internist (Berl)       Date:  2005-06       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.